biotech · Dental Caries · Cystic Fibrosis · ARMP
Armata Pharmaceuticals
Armata Pharmaceuticals is a biotech organization headquartered in Freehold, USA. It trades on NYSE under ticker ARMP. Primary therapeutic focus areas include Dental Caries, Cystic Fibrosis, Non-cystic Fibrosis Bronchiect
Company details
- Status
- Public
- HQ
- Freehold, USA
- Founded
- 2018
- Employees
- 18
- Programs
- 9
- Drugs
- 0
- Patents
- 5
C16G2 Strip
Phase 2 · small molecule · Dental Caries
C16G2 Strip for Dental Caries is a Phase 2 program (small_molecule) at Armata Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Internal code C3J16-S205-00
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Armata Pharmaceuticals
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Dental Caries
- Status
- completed
- Trials
- 1